David J. Lim
7Patents
5h-index
12Co-inventors
56Inventor score
Filing activity: Apr 23, 1997 → Apr 21, 2010
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6716813B2 | Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis | Human Necessities | 162 | Expired |
| US6207157A | Conjugate vaccine for nontypeable Haemophilus influenzae | Emerging Cross-Sectional Technologies | 60 | Expired |
| US6607725B2 | Conjugate vaccine for nontypeable Haemophilus influenzae | Emerging Cross-Sectional Technologies | 7 | Expired |
| US7060674B2 | Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis | Human Necessities | 7 | Expired |
| US7338936B2 | Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis | Chemistry; Metallurgy | 7 | Expired |
| US7985729B2 | Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis | Chemistry; Metallurgy | 2 | Active |
| US6358688B1 | Immortalized human middle ear epithelial cell lines | Chemistry; Metallurgy | 0 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.